Provided by Tiger Fintech (Singapore) Pte. Ltd.

SIGA Technologies Inc.

5.71
+0.24004.39%
Post-market: 5.70-0.0100-0.18%18:53 EST
Volume:404.32K
Turnover:2.26M
Market Cap:407.72M
PE:4.78
High:5.75
Open:5.41
Low:5.36
Close:5.47
Loading ...

Siga Technologies (SIGA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Zacks
·
05 Dec 2024

Why SIGA Technologies (SIGA) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Insider Monkey
·
01 Dec 2024

Are Investors Undervaluing Siga Technologies (SIGA) Right Now?

Zacks
·
21 Nov 2024

Impressive Earnings May Not Tell The Whole Story For SIGA Technologies (NASDAQ:SIGA)

Simply Wall St.
·
15 Nov 2024

SIGA Technologies Third Quarter 2024 Earnings: EPS: US$0.019 (vs US$0.006 loss in 3Q 2023)

Simply Wall St.
·
09 Nov 2024

SIGA Technologies Inc (SIGA) Q3 2024 Earnings Call Highlights: Strong Procurement Orders and ...

GuruFocus.com
·
08 Nov 2024

SIGA Technologies Q3 EPS $0.02 Up From $(0.01) YoY, Sales $10.00M Up From $9.23M YoY

Benzinga
·
08 Nov 2024

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024

THOMSON REUTERS
·
08 Nov 2024

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024

GlobeNewswire
·
08 Nov 2024

SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

GlobeNewswire
·
31 Oct 2024

Siga Technologies Inc. (SIGA) Falls More Steeply Than Broader Market: What Investors Need to Know

Zacks
·
31 Oct 2024

Three Undiscovered Gems With Promising Potential

Simply Wall St.
·
30 Oct 2024

Siga Technologies Inc. (SIGA) Stock Moves -0.6%: What You Should Know

Zacks
·
24 Oct 2024

SIGA Strikes License Deal for Poxvirus Monoclonal Antibodies

MT Newswires Live
·
22 Oct 2024

Siga Technologies enters exclusive license agreement with Vanderbilt University

TIPRANKS
·
22 Oct 2024

SIGA Enters Into Exclusive License Agreement With Vanderbilt University for Novel Poxvirus Monoclonal Antibodies

THOMSON REUTERS
·
22 Oct 2024